GWM
ABBV icon

Gibbs Wealth Management’s AbbVie ABBV Stock Holding History

Gibbs Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.44M Buy
11,233
+7,199
+178% +$1.6M 0.32% 54
2025
Q4 		$888K Sell
4,034
-217
-5% -$49.4K 0.21% 112
2025
Q3 		$984K Sell
4,251
-2,069
-33% -$421K 0.22% 106
2025
Q2 		$1.17M Buy
6,320
+2,211
+54% +$411K 0.23% 103
2025
Q1 		$861K Buy
4,109
+868
+27% +$169K 0.21% 108
2024
Q4 		$576K Buy
3,241
+575
+22% +$106K 0.16% 143
2024
Q3 		$526K Buy
2,666
+460
+21% +$85.9K 0.17% 139
2024
Q2 		$378K Buy
2,206
+319
+17% +$52.8K 0.15% 156
2024
Q1 		$344K Buy
+1,887
New +$325K 0.2% 123

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Gibbs Wealth Management's ABBV Position: Q1 2026 in Review

Gibbs Wealth Management increased its AbbVie (ABBV) stake by 178% in Q1 2026, buying an estimated $1.6M and bringing the position to 11,233 shares worth $2.44M. The position accounts for 0.32% of the portfolio, ranked #54.

Gibbs Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,116 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Gibbs Wealth Management held 11,233 shares of AbbVie worth $2.44M as of Q1 2026.
  • Gibbs Wealth Management bought 7,199 AbbVie shares in Q1 2026, an estimated $1.6M.
  • AbbVie made up 0.32% of Gibbs Wealth Management's portfolio in Q1 2026, its #54 holding.
  • Gibbs Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • 4,116 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.